Eman E. Ahwany-El
Giza, GZ, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Development of an innovative nanopolymer-lncRNA-SRHC complex as therapeutic modalities for targeted hepatocellular carcinoma therapy.
Journal: Scientific reports
Published: April 12, 2026
Therapeutic potential of miRNA-26a-encapsulated nanoparticles against hepatocellular carcinoma in a murine model.
Journal: Liver research (Beijing, China)
Published: August 10, 2024
Innovative model of surface-enhanced Raman spectroscopy for exosomes identification: An approach for the diagnosis of hepatocellular carcinoma.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: September 25, 2022
MicroRNA-122 mimic/microRNA-221 inhibitor combination as a novel therapeutic tool against hepatocellular carcinoma.
Journal: Non-coding RNA research
Published: August 28, 2022
Nanoconjugated long non-coding RNA MEG3 as a new therapeutic approach for Hepatocellular carcinoma.
Journal: Heliyon
Published: May 26, 2022
Albendazole-loaded cubosomes interrupt the ERK1/2-HIF-1α-p300/CREB axis in mice intoxicated with diethylnitrosamine: A new paradigm in drug repurposing for the inhibition of hepatocellular carcinoma progression.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 04, 2021
Taurine Upregulates miRNA-122-5p Expression and Suppresses the Metabolizing Enzymes of Glycolytic Pathway in Hepatocellular Carcinoma.
Journal: Molecular biology reports
Published: April 22, 2021
MicroRNA-195 vector influence on the development of gradually induced hepatocellular carcinoma in murine model.
Journal: Ultrastructural pathology
Published: March 29, 2020
Effects of free and nanoparticulate curcumin on chemically induced liver carcinoma in an animal model.
Journal: Archives of medical science : AMS
Published: July 07, 2018
Expression analysis of liver-specific circulating microRNAs in HCV-induced hepatocellular Carcinoma in Egyptian patients.
Journal: Cancer biology & therapy
Published: January 16, 2018
Liver Protective Effects of Renin-Angiotensin System Inhibition Have No Survival Benefits in Hepatocellular Carcinoma Induced By Repetitive Administration of Diethylnitrosamine in Mice.
Journal: Open access Macedonian journal of medical sciences
Published: November 02, 2017
Last Updated: 09/26/2026